Comprehensive Genetic Analysis of 128 Candidate Genes in a Cohort With Idiopathic, Severe, or Familial Osteoporosis

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ENDOCRINE SOC
Citação
JOURNAL OF THE ENDOCRINE SOCIETY, v.4, n.12, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context: The genetic bases of osteoporosis (OP), a disorder with high heritability, are poorly understood at an individual level. Cases of idiopathic or familial OP have long puzzled clinicians as to whether an actionable genetic cause could be identified. Objective: We performed a genetic analysis of 28 cases of idiopathic, severe, or familial osteoporosis using targeted massively parallel sequencing. Design: Targeted sequencing of 128 candidate genes was performed using Illumina NextSeq. Variants of interest were confirmed by Sanger sequencing or SNP array. Patients and Setting: Thirty-seven patients in an academic tertiary hospital participated (54% male; median age, 44 years; 86% with fractures), corresponding to 28 sporadic or familial cases. Main Outcome Measure: The identification of rare stop-gain, indel, splice site, copy-number, or nonsynonymous variants altering protein function. Results: Altogether, we identified 28 variants of interest, but only 3 were classified as pathogenic or likely pathogenic variants: COL1A2 p.(Arg708Gln), WNT1 p.(Gly169Asp), and IDUA p.(His82Gln). An association of variants in different genes was found in 21% of cases, including a young woman with severe OP bearing WNT1, PLS3, and NOTCH2 variants. Among genes of uncertain significance analyzed, a potential additional line of evidence has arisen for GWAS candidates GPR68 and NBR1, warranting further studies. Conclusions: While we hope that continuing efforts to identify genetic predisposition to OP will lead to improved and personalized care in the future, the likelihood of identifying actionable pathogenic variants in intriguing cases of idiopathic or familial osteoporosis is seemingly low.
Palavras-chave
idiopathic osteoporosis, familial osteoporosis, bone fragility, genetic analysis, candidate genes, targeted massively parallel sequencing
Referências
  1. Arden NK, 1996, J BONE MINER RES, V11, P530
  2. Bravo H, 2017, MOL GENET METAB REP, V12, P92, DOI 10.1016/j.ymgmr.2017.06.006
  3. Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357
  4. Christensen KM., 2013, AM SOC HUMAN GENETIC
  5. Collet Corinne, 2018, JBMR Plus, V2, P12, DOI 10.1002/jbm4.10020
  6. Crabbe P, 2005, J BONE MINER RES, V20, P1951, DOI 10.1359/JBMR.050705
  7. Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733
  8. Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372
  9. Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249
  10. Forlino A, 1998, MATRIX BIOL, V17, P575, DOI 10.1016/S0945-053X(98)90109-3
  11. Franceschi R, 2015, CALCIFIED TISSUE INT, V96, P575, DOI 10.1007/s00223-015-9983-7
  12. Francis C, 2015, HEART, V101, pA99, DOI 10.1136/heartjnl-2015-308066.175
  13. Funck-Brentano T, 2017, JOINT BONE SPINE, V84, P715, DOI 10.1016/j.jbspin.2016.11.014
  14. Ghosh R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1353-5
  15. Guo Y, 2010, J BONE MINER RES, V25, P1042, DOI 10.1359/jbmr.091040
  16. Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806
  17. Hartikka H, 2005, J BONE MINER RES, V20, P783, DOI 10.1359/JBMR.050101
  18. Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977
  19. Hwang JY, 2013, J MED GENET, V50, P212, DOI 10.1136/jmedgenet-2012-101156
  20. Kanis JA, 2017, OSTEOPOROSIS INT, V28, P2023, DOI 10.1007/s00198-017-4009-0
  21. Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949
  22. Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903
  23. Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014
  24. Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458
  25. Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705
  26. Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827
  27. Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160
  28. Liu Y, 2016, CLIN CHIM ACTA, V461, P172, DOI 10.1016/j.cca.2016.07.012
  29. Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
  30. Oei L, 2014, J MED GENET, V51, P122, DOI 10.1136/jmedgenet-2013-102064
  31. Parry DA, 2016, AM J HUM GENET, V99, P984, DOI 10.1016/j.ajhg.2016.08.020
  32. PHILLIPS CL, 1990, J CLIN INVEST, V86, P1723, DOI 10.1172/JCI114897
  33. Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016
  34. Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1
  35. Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
  36. Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446
  37. Rocha-Braz MGM, 2016, ARCH ENDOCRIN METAB, V60, P391, DOI 10.1590/2359-3997000000178
  38. Slemenda CW, 1996, OSTEOPOROSIS INT, V6, P178, DOI 10.1007/BF01623944
  39. Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197
  40. Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124
  41. Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284
  42. Tan LJ, 2015, J CLIN ENDOCR METAB, V100, pE1457, DOI 10.1210/jc.2015-2095
  43. Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404
  44. Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052
  45. van Dijk FS, 2013, NEW ENGL J MED, V369, P1529, DOI 10.1056/NEJMoa1308223
  46. Vomund AN, 2004, MOL GENET METAB, V82, P144, DOI 10.1016/j.ymgme.2004.03.004
  47. Whitehouse CA, 2010, P NATL ACAD SCI USA, V107, P12913, DOI 10.1073/pnas.0913058107
  48. Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025
  49. Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200
  50. Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006
  51. Yogalingam G, 2004, HUM MUTAT, V24, P199, DOI 10.1002/humu.20081
  52. Zhang L, 2014, HUM MOL GENET, V23, P1923, DOI 10.1093/hmg/ddt575
  53. Zhang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021835
  54. Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745